WuXi AppTec Completes Acquisition of OXGENE to Further Strengthen Cell and Gene Therapy Service Offerings for Global Customers
WuXi AppTec
PR-M11-20-040Mar 02, 2021
Capacity Expansion
WuXi Advanced Therapies Expands Philadelphia Campus with New State-of-the-Art Testing Laboratory
WuXi AppTec
PR-M11-20-019Nov 19, 2020
CAR-T Cell Therapy
WuXi Advanced Therapies Launches New Closed Process CAR-T Cell Therapy Platform
WuXi Advanced Therapies
PR-M05-20-NI-025May 18, 2020
Expanded Capacity
WuXi STA Opens Oligonucleotide Large-Scale Manufacturing Facility
WuXi STA
PR-M01-20-NI-010Jan 07, 2020
Collaboration
Altasciences and WuXi AppTec Enter Into Collaboration for WIND Projects
Nice Insight
PR-M05-19-NI-073May 24, 2019
M&A
WuXi AppTec Acquires Pharmapace to Enhance Biometrics Services for Clinical Development
WuXi AppTec
PR-M05-19-NI-030May 10, 2019
Healthcare
The First WuXi Healthcare Forum Opens in Shanghai
WuXi AppTec
PR-M03-19-NI-019Mar 06, 2019
Growth
WuXi AppTec Plans for Growth
Emilie Branch
Pharma's Almanac
PAO-M12-18-NI-005-10Dec 11, 2018
Awards
WuXi AppTec Receives 2018 Global Integrated Drug R&D Services Competitive Strategy Innovation & Leadership Award from Frost & Sullivan
WuXi AppTec
PR-M12-18-NI-008Dec 04, 2018
Announcement
WuXi AppTec Group and Mayo Clinic Receive 2018 MedTech Insight Award for Best Alliance
WuXi AppTec
PR-M10-18-NI-029Oct 09, 2018
Artificial Intelligence
WuXi AppTec Research Service Division and Cyclica Collaborate to Drive Polypharmacology in Drug Discovery Through AI-Augmented Technologies
WuXi AppTec
PR-M09-18-NI-054Sep 19, 2018
Drug Approval
WuXi STA First CDMO to Support the Approval of an Innovative Drug in China Through the "MAH" Pilot
WuXi AppTec
PR-M06-18-NI-057Jun 18, 2018
Artificial Intelligence
WuXi AppTec Leads Strategic Investment in Insilico Medicine to Accelerate Drug Discovery Using Next-Generation Artificial Intelligence
WuXi AppTec
PR-M06-18-NI-037Jun 12, 2018
Novel Medicine
WuXi Laboratory Testing Division: Propelling Innovation and Better Treatments for Patients
WuXi AppTec
PAO-M05-18-CL-004May 25, 2018
IPO
WuXi AppTec Announces Listing of Initial Public Offering of Common Stock on Shanghai Stock Exchange
WuXi AppTec
PR-M05-18-NI-037May 08, 2018
Expanded Capacity
WuXi STA to Build a New R&D Center in Shanghai
WuXi AppTec
PR-M05-18-NI-001May 01, 2018
Drug Candidate
STA Pharmaceutical Co. to Manufacture Phoenix Molecular Designs’ Anticancer Candidate
Cynthia A. Challener, Ph.D.
Pharma's Almanac
PAO-M04-18-NI-018Apr 26, 2018
Expanded Capacity
WuXi AppTec Expands Site in the U.S. for Drug Development Testing Services
WuXi AppTec
PR-M04-18-NI-75Apr 19, 2018
Partnership
Nohla Therapeutics Selects Advanced Therapies Business Unit of WuXi AppTec to Manufacture Universal Donor Cell Therapies
WuXi AppTec
PR-M03-18-NI-090Mar 26, 2018
Genomics
WuXi NextCODE Unveils Genomics Partnership with Google Cloud
WuXi NextCODE
PR-M03-18-NI-036Mar 09, 2018